MindMed to Host Earnings Call to Discuss Full-Year 2021 Financial Results and Provide Business Update

Rhea-AI Summary

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) will host an earnings call on March 28, 2022, at 8:30 a.m. EDT, to discuss its financial results for the full year ending December 31, 2021, and provide a business update. The call will address the company’s ongoing developments in brain health treatments, particularly focusing on psychiatry and neurology. Participants can join via telephone or access the live webcast through the provided link. This call marks a significant moment for investors seeking insights into MindMed’s performance and future direction.

News Market Reaction – MNMD

-3.33%

-3.33% Session move

In the trading session that priced this news, MNMD declined 3.33%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, March 21, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that it will host its earnings call on Monday, March 28, 2022, at 8:30 a.m. EDT to discuss its financial results for the full year ended December 31, 2021 and provide a business update.

Individuals may participate via telephone by dialing (877) 407-0789 (domestic) or (201) 689-8562 (international) and using conference ID 13728028. The webcast can be accessed live here or on MindMed's Investor Resources webpage. The webcast will be archived on the company's website for at least 30 days after the conference call.

About MindMed

MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

For Investors: ir@mindmed.co

For Media: media@mindmed.co

View original content to download multimedia:https://www.prnewswire.com/news-releases/mindmed-to-host-earnings-call-to-discuss-full-year-2021-financial-results-and-provide-business-update-301506279.html

SOURCE Mind Medicine (MindMed) Inc.

FAQ

What date will MindMed host its earnings call for the full year 2021 results?

MindMed will host its earnings call on March 28, 2022.

What time is MindMed's earnings call scheduled for?

The earnings call is scheduled for 8:30 a.m. EDT.

How can I participate in MindMed's earnings call?

You can participate by dialing 877-407-0789 for domestic calls or 201-689-8562 for international calls.

What financial results will MindMed discuss during the earnings call?

MindMed will discuss its financial results for the full year ended December 31, 2021.

Where can I find the webcast of MindMed's earnings call?

The webcast can be accessed live on MindMed's Investor Resources webpage.